BOSS ZHIPIN-W
02076
TME-SW
01698
BIDU-SW
09888
NTES-S
09999
JD HEALTH
06618
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 21.20%2.36B | 17.68%1.01B | -14.64%1.95B | -11.69%855.91M | -5.20%2.28B | -5.06%969.18M | 18.24%2.4B | 39.96%1.02B | -12.01%2.03B | -27.42%729.39M |
Operating income | 21.20%2.36B | 17.68%1.01B | -14.64%1.95B | -11.69%855.91M | -5.20%2.28B | -5.06%969.18M | 18.24%2.4B | 39.96%1.02B | -12.01%2.03B | -27.42%729.39M |
Cost of sales | -20.90%-1.73B | -15.39%-757.19M | 17.56%-1.43B | 16.75%-656.19M | 5.30%-1.74B | -1.25%-788.25M | -22.28%-1.84B | -37.33%-778.54M | 8.68%-1.5B | 22.19%-566.91M |
Operating expenses | -20.90%-1.73B | -15.39%-757.19M | 17.56%-1.43B | 16.75%-656.19M | 5.30%-1.74B | -1.25%-788.25M | -22.28%-1.84B | -37.33%-778.54M | 8.68%-1.5B | 22.19%-566.91M |
Gross profit | 22.04%625.83M | 25.18%250.02M | -5.26%512.79M | 10.39%199.73M | -4.90%541.28M | -25.32%180.94M | 6.86%569.17M | 49.12%242.29M | -20.20%532.63M | -41.21%162.48M |
Selling expenses | -23.75%-71M | -21.97%-34.31M | 14.39%-57.38M | 14.74%-28.13M | 15.44%-67.02M | 15.86%-33M | -11.42%-79.25M | -21.90%-39.21M | 11.85%-71.13M | 10.14%-32.17M |
Administrative expenses | -10.63%-304.41M | -8.07%-135.53M | 3.10%-275.15M | 2.82%-125.41M | -14.96%-283.95M | -4.43%-129.05M | 3.03%-247M | -11.92%-123.57M | 5.51%-254.72M | 6.14%-110.42M |
Impairment and provision | -287.47%-5.58M | -268.08%-3.52M | -10.19%2.98M | --2.09M | --3.32M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -287.47%-5.58M | -268.08%-3.52M | -10.19%2.98M | --2.09M | --3.32M | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 33.65%68.79M | 28.91%25.38M | -4.91%51.47M | -44.96%19.69M | -14.01%54.13M | -7.26%35.78M | 124.21%62.95M | 44.20%38.58M | -36.63%28.07M | 89.79%26.76M |
Operating profit | 33.62%313.63M | 50.12%102.05M | -5.26%234.72M | 24.33%67.98M | -19.00%247.75M | -53.70%54.67M | 30.23%305.86M | 153.12%118.09M | -35.04%234.86M | -65.96%46.65M |
Financing income | 2.95%23.47M | -7.88%10.8M | -2.55%22.8M | -18.12%11.72M | -4.57%23.39M | 10.59%14.31M | 63.15%24.51M | 90.53%12.94M | -25.69%15.03M | -37.19%6.79M |
Financing cost | 63.95%-4.5M | 69.62%-2.4M | -24.38%-12.49M | -120.29%-7.9M | -57.43%-10.04M | -1.30%-3.59M | 36.18%-6.38M | 38.93%-3.54M | 53.78%-9.99M | 46.83%-5.8M |
Share of profits of associates | 107.68%617K | 111.54%1M | -242.22%-8.03M | -2,212.93%-8.66M | -545.35%-2.35M | -78.97%410K | -18.92%527K | 390.61%1.95M | 75.20%650K | ---671K |
Earning before tax | 40.60%333.21M | 76.53%111.44M | -8.41%236.99M | -4.07%63.13M | -20.26%258.76M | -49.16%65.81M | 34.91%324.52M | 175.56%129.43M | -33.28%240.54M | -65.70%46.97M |
Tax | -117.54%-71.36M | -276.05%-31.7M | -3.00%-32.8M | -14.62%-8.43M | 24.42%-31.85M | 48.37%-7.35M | -36.56%-42.14M | -153.66%-14.24M | 47.43%-30.86M | 75.39%-5.62M |
After-tax profit from continuing operations | 28.24%261.85M | 45.78%79.74M | -10.01%204.19M | -6.42%54.7M | -19.64%226.91M | -49.26%58.45M | 34.67%282.38M | 178.53%115.19M | -30.52%209.69M | -63.76%41.36M |
Earning after tax | 28.24%261.85M | 45.78%79.74M | -10.01%204.19M | -6.42%54.7M | -19.64%226.91M | -49.26%58.45M | 34.67%282.38M | 178.53%115.19M | -30.52%209.69M | -63.76%41.36M |
Profit attributable to shareholders | 28.24%261.85M | 45.78%79.74M | -10.01%204.19M | -6.42%54.7M | -19.64%226.91M | -49.26%58.45M | 34.67%282.38M | 178.53%115.19M | -30.52%209.69M | -63.76%41.36M |
Basic earnings per share | 28.00%0.32 | 45.45%0.096 | -7.41%0.25 | -5.71%0.066 | -20.59%0.27 | -49.64%0.07 | 36.00%0.34 | 178.00%0.139 | -30.56%0.25 | -63.50%0.05 |
Diluted earnings per share | 28.00%0.32 | 45.45%0.096 | -7.41%0.25 | -5.71%0.066 | -20.59%0.27 | -49.64%0.07 | 36.00%0.34 | 178.00%0.139 | -30.56%0.25 | -63.50%0.05 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.